Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Dosimetric benefit of adaptive re-planning in pancreatic cancer stereotactic body radiotherapy
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Dosimetric benefit of adaptive re-planning in pancreatic cancer stereotactic body radiotherapy
Dosimetric benefit of adaptive re-planning in pancreatic cancer stereotactic body radiotherapy. Medical Dosimetry. 2015; 40(4):318-324.
authors with profiles
Zhen Tian